Triclopyr

Triclopyr

SCHEMBL149659

O=C(O)COc1nc(Cl)c(Cl)cc1Cl.O=C(O)COc1nc(Cl)c(Cl)cc1Cl

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 4/20 0.45
KMT2A Q03164 2/20 0.44
KDM4E B2RXH2 2/20 0.44
PKM P14618 1/20 0.44
HTT P42858 1/20 0.44
HIF1A Q16665 1/20 0.43
MCL1 Q07820 1/20 0.42
TSHR P16473 2/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP3A4 P08684 1/20 0.41
MAPT P10636 1/20 0.41
ALOX15 P16050 1/20 0.41
ALOX12 P18054 1/20 0.41
MAPK1 P28482 1/20 0.41
ATM Q13315 1/20 0.41
HSD17B10 Q99714 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
PTGDR Q13258 3/20 0.40
PTGDR2 Q9Y5Y4 3/20 0.40
MEN1 O00255 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Triclopyr SCHEMBL29350609 1.00 TDP1 (0.45) TDP1KMT2AKDM4EPKMHTT
Triclopyr SCHEMBL37162 1.00 TDP1 (0.45) TDP1KMT2AKDM4EPKMHTT
Triclopyr SCHEMBL29225326 0.98 TDP1 (0.44) TDP1KMT2AKDM4EPKMHTT
Triclopyr SCHEMBL28924114 0.98 TDP1 (0.44) TDP1KMT2AKDM4EPKMHTT
Triclopyr SCHEMBL4149847 0.98 TDP1 (0.44) TDP1KMT2AKDM4EPKMHTT
Triclopyr SCHEMBL25394124 0.98 TDP1 (0.44) TDP1KMT2AKDM4EPKMHTT
Triclopyr SCHEMBL29157738 0.98 TDP1 (0.44) TDP1KMT2AKDM4EPKMHTT
Triclopyr SCHEMBL27754379 0.98 TDP1 (0.44) TDP1KMT2AKDM4EPKMHTT
Triclopyr SCHEMBL23633000 0.95 KDM4E (0.45) TDP1KMT2AKDM4EPKMHTT
Triclopyr SCHEMBL29007141 0.94 KDM4E (0.41) TDP1KMT2AKDM4EPKMHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4522767-A1 ENRICHMENT METHODS AND KITS Illumina, Inc. (US) 2025-03-19 EP claimed
WO-2024187052-A1 ENRICHMENT METHODS AND KITS ILLUMINA, INC. (US) 2024-09-12 WO claimed
EP-4676977-A1 MULTIFUNCTIONAL ANTIBODIES Telix Pharmaceuticals (Innovations) Pty Ltd (AU) 2026-01-14 EP disclosed
EP-4654993-A1 DEVELOPING A CAR-ENGAGER PLATFORM TO ENHANCE THE FUNCTIONALITY AND/OR PERSISTENCE OF CAR T CELLS Dana-Farber Cancer Institute, Inc. (US) 2025-12-03 EP disclosed
WO-2025235931-A2 ANTIBODY STRUCTURES COMPRISING HELICAL COMPLEMENTARITY DETERMINING REGIONS APTAMINO, LLC (US) 2025-11-13 WO disclosed
EP-4244377-B1 FUNCTIONALIZED PLASMONIC NANOSTRUCTURES ILLUMINA CAMBRIDGE LTD (GB) 2025-10-29 EP disclosed
EP-4594530-A1 NUCLEIC ACID SEQUENCING COMPONENTS INCLUDING A GLYCOLIPID BI-LAYER Illumina, Inc. (US) 2025-08-06 EP disclosed
EP-4590711-A1 ANTI-CCR8 ANTIBODIES Monash University (AU) 2025-07-30 EP disclosed
WO-2025075875-A1 TAGMENTATION METHODS AND KITS ILLUMINA, INC. (US) 2025-04-10 WO disclosed
WO-2025072677-A1 TAGMENTATION METHODS AND KITS ILLUMINA, INC. (US) 2025-04-03 WO disclosed
WO-2025059162-A1 CAR-ENGAGER CONTAINING IL-2 VARIANTS TO ENHANCE THE FUNCTIONALITY OF CAR T CELLS DANA-FARBER CANCER INSTITUTE, INC. (US) 2025-03-20 WO disclosed
US-20120021908-A1 HERBICIDAL COMPOSITION AND METHOD OF USE THEREOF Synegenta Crop Protection Inc. (US) 2012-01-26 US disclosed
EP-2405759-A2 HERBICIDAL FORMULATIONS COMPRISING GLYPHOSATE AND ALKOXYLATED GLYCERIDES Monsanto Technology LLC (US) 2012-01-18 EP disclosed
EP-2385756-A1 SOYBEAN EVENT 127 AND METHODS RELATED THERETO BASF Agrochemical Products, B.V. (NL) 2011-11-16 EP disclosed
US-8041483-B2 Exterior airbag deployment techniques AUTOMOTIVE TECHNOLOGIES INTERNATIONAL, INC. (US) 2011-10-18 US disclosed
EP-2342331-A2 HERBICIDE-RESISTANT AHAS-MUTANTS AND METHODS OF USE BASF Agrochemical Products, B.V. (NL) 2011-07-13 EP disclosed
US-20110111961-A1 SURFACTANT BLENDS USEFUL IN AGRICULTURE AKZO NOBEL N.V. (NL) 2011-05-12 US disclosed
WO-2011019652-A2 LOW VOLATILITY AUXIN HERBICIDE FORMULATIONS MONSANTO TECHNOLOGY LLC (US) 2011-02-17 WO disclosed
US-6927244-B2 Comprises diene-ethylene-propylene copolymer mixed with sulfur-containing/mercapto-based silane coupling agent to reduce stiffness TOKAI RUBBER INDUSTRIES, LTD. (JP) 2005-08-09 US disclosed
US-20050043181-A1 Carbamoyl triazolinone-based herbicides FEUCHT DIETER (DE) 2005-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050043181-A1 Carbamoyl triazolinone-based herbicides DDT, GATD3, AADAC TDP1 2169/4885KMT2A 207/4885KDM4E 537/4885
US-20110111961-A1 SURFACTANT BLENDS USEFUL IN AGRICULTURE ATL3, AGXT, ABHD5 TDP1 2022/4885KMT2A 1852/4885KDM4E 713/4885
US-20120021908-A1 HERBICIDAL COMPOSITION AND METHOD OF USE THEREOF DDT, TH, MTX2 TDP1 1519/4885KMT2A 2234/4885KDM4E 2553/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.